New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

7 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato
Fundraising
Microbiotica

Microbiotica Raises £36M Series C for Oral Microbiome Medicines

Microbiotica announced the first close of a £36 million ($48 million) Series C led by British Business Bank to advance MB310 into Phase 2 clinical development in ulcerative colitis.

SalesTools Research
Oct 16, 2026
2 min read•£36M ($48M)
Biotech
Vedanta Biosciences

Vedanta Biosciences raises $108M Series D at $550M valuation

Vedanta Biosciences raises $108M in Series D at $550M valuation. Microbiome-derived therapeutics...

Editorial Team
Oct 31, 2024
0 min read•$108M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
AgTech
Trace Genomics

Trace Genomics Headquarters - Office Location & Address

Discover Trace Genomics's headquarters at 225 Bush St, San Francisco, CA 94104. Soil microbiome analysis. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
AgTech
Biome Makers

Biome Makers Headquarters - Office Location & Address

Discover Biome Makers's headquarters at 1451 Harbor Bay Pkwy, West Sacramento, CA 95691. Soil microbiome intelligence platform. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Fundraising
Vedanta Biosciences

Vedanta Biosciences Raises $108M in Series D

Vedanta Biosciences, a Biotech company based in 501 Boylston Street, Boston, MA 02116, has raised $108M in Series D at a $550M valuation led by Johnson & Johnson Innovation, Mitsui & Co, Puretech Health, Flagship Pioneering.

Fundraising News Team
Oct 31, 2024
0 min read
Fundraising
Seres Therapeutics

Seres Therapeutics Raises $113M in Series E

Seres Therapeutics, a Biotech company based in 200 Sidney Street, Cambridge, MA 02139, has raised $113M in Series E at a $450M valuation led by Flagship Pioneering, Polaris Partners, Fidelity, Nestle Health Science, Takeda Ventures.

Fundraising News Team
Jan 19, 2024
0 min read
Pagina 1

Visualizzazione di 7 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.